• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.30 0.30
(0.00%)
Sensex
83,442.50 9.61
( 0.01%)
Bank Nifty
56,949.20 -82.70
( -0.15%)
Nifty IT
38,866.95 -299.60
( -0.76%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,300.35 51.93
(0.83%)
Hang Seng
39,585.13 -225.75
(-0.57%)
Nikkei 225
8,806.53 -16.38
(-0.19%)
Forex
USD-INR
85.44 -0.20
(-0.23%)
EUR-INR
100.61 -0.32
(-0.32%)
GBP-INR
116.59 -0.52
(-0.45%)
JPY-INR
0.59 0.00
(-0.64%)

EQUITY - MARKET SCREENER

Lime Chemicals Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
507759
INE891G01011
2.9897146
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
50.21
11.1
EPS(TTM)
Face Value()
Div & Yield %
0.34
10
0
 

corom&el international ltd
Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.
May 24,2025
Divis Laboratories has entered into a long term manufacturing and supply agreement with a global pharma company.

Under this agreement, the Company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties.

The Company expects meaningful revenue contribution from this long-term agreement.

Cost of capacity addition for manufacturing under this agreement is estimated to be Rs.650-750 crore, which will be funded from the capacity reservation advance proposed to be paid by the customer phase wise under this Agreement.